These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 19968503)

  • 21. ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells.
    Klos KS; Wyszomierski SL; Sun M; Tan M; Zhou X; Li P; Yang W; Yin G; Hittelman WN; Yu D
    Cancer Res; 2006 Feb; 66(4):2028-37. PubMed ID: 16489002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells.
    Merighi S; Benini A; Mirandola P; Gessi S; Varani K; Simioni C; Leung E; Maclennan S; Baraldi PG; Borea PA
    Mol Pharmacol; 2007 Aug; 72(2):395-406. PubMed ID: 17488804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular endothelial growth factor as an autocrine survival factor for retinal pigment epithelial cells under oxidative stress via the VEGF-R2/PI3K/Akt.
    Byeon SH; Lee SC; Choi SH; Lee HK; Lee JH; Chu YK; Kwon OW
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1190-7. PubMed ID: 19834034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High VEGFR-3-positive circulating lymphatic/vascular endothelial progenitor cell level is associated with poor prognosis in human small cell lung cancer.
    Bogos K; Renyi-Vamos F; Dobos J; Kenessey I; Tovari J; Timar J; Strausz J; Ostoros G; Klepetko W; Ankersmit HJ; Lang G; Hoda MA; Nierlich P; Dome B
    Clin Cancer Res; 2009 Mar; 15(5):1741-6. PubMed ID: 19240177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of catalytically inactive phospholipase Cbeta disrupts phospholipase Cbeta and mitogen-activated protein kinase signaling and inhibits small cell lung cancer growth.
    Beekman A; Helfrich B; Bunn PA; Heasley LE
    Cancer Res; 1998 Mar; 58(5):910-3. PubMed ID: 9500449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imatinib mesylate efficiently achieves therapeutic intratumor concentrations in vivo but has limited activity in a xenograft model of small cell lung cancer.
    Wolff NC; Randle DE; Egorin MJ; Minna JD; Ilaria RL
    Clin Cancer Res; 2004 May; 10(10):3528-34. PubMed ID: 15161712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancer.
    Dalwadi H; Krysan K; Heuze-Vourc'h N; Dohadwala M; Elashoff D; Sharma S; Cacalano N; Lichtenstein A; Dubinett S
    Clin Cancer Res; 2005 Nov; 11(21):7674-82. PubMed ID: 16278387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitogen-activated protein kinase phosphatase-1 modulated JNK activation is critical for apoptosis induced by inhibitor of epidermal growth factor receptor-tyrosine kinase.
    Takeuchi K; Shin-ya T; Nishio K; Ito F
    FEBS J; 2009 Mar; 276(5):1255-65. PubMed ID: 19175673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
    Grau R; Iñiguez MA; Fresno M
    Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The protective effects of urocortin1 against intracerebral hemorrhage by activating JNK1/2 and p38 phosphorylation and further increasing VEGF via corticotropin-releasing factor receptor 2.
    Xu S; Wu Q; Guo G; Ding X
    Neurosci Lett; 2015 Mar; 589():31-6. PubMed ID: 25576701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Notch1 signaling controls cell proliferation, apoptosis and differentiation in lung carcinoma.
    Wael H; Yoshida R; Kudoh S; Hasegawa K; Niimori-Kita K; Ito T
    Lung Cancer; 2014 Aug; 85(2):131-40. PubMed ID: 24888228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of metastases of small cell lung cancer cells in mice by a peptidic CXCR4 inhibitor TF14016.
    Otani Y; Kijima T; Kohmo S; Oishi S; Minami T; Nagatomo I; Takahashi R; Hirata H; Suzuki M; Inoue K; Takeda Y; Kida H; Tachibana I; Fujii N; Kumanogoh A
    FEBS Lett; 2012 Oct; 586(20):3639-44. PubMed ID: 22992418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Inhibitory effects of Notch1 overexpression on proliferation and neuroendocrine marker expression in a small cell lung cancer cell line].
    Wang JX; Zhang XM; Wang LL; Cheng H; Yao GY
    Zhonghua Zhong Liu Za Zhi; 2009 May; 31(5):335-9. PubMed ID: 19799080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Visfatin Mediates SCLC Cells Migration across Brain Endothelial Cells through Upregulation of CCL2.
    Liu T; Miao Z; Jiang J; Yuan S; Fang W; Li B; Chen Y
    Int J Mol Sci; 2015 May; 16(5):11439-51. PubMed ID: 25993304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knocking down the expression of Aurora-A gene inhibits cell proliferation and induces G2/M phase arrest in human small cell lung cancer cells.
    Lu Y; Liu Y; Jiang J; Xi Z; Zhong N; Shi S; Wang J; Wei X
    Oncol Rep; 2014 Jul; 32(1):243-9. PubMed ID: 24841948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of proNT/NMN secretion from small cell lung carcinoma cells using a mouse xenograft model.
    Wakabayashi-Nakao K; Maruyama K; Ishii H; Muramatsu K; Hatakeyama K; Ohshima K; Ogura S; Nakajima T; Yamaguchi K; Mochizuki T
    Oncol Rep; 2012 Oct; 28(4):1181-6. PubMed ID: 22825476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small cell lung carcinoma with marked bronchial epithelial involvement.
    Rosen Y; Durie NM
    Int J Surg Pathol; 2011 Aug; 19(4):538-43. PubMed ID: 21632633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased insulin-like growth factor 1 receptor (IGF1R) expression in small cell lung cancer and the effect of inhibition of IGF1R expression by RNAi on growth of human small cell lung cancer NCI-H446 cell.
    Wang Z; Lu P; Liang Z; Zhang Z; Shi W; Cai X; Chen C
    Growth Factors; 2015; 33(5-6):337-46. PubMed ID: 26430715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anti-apoptotic mechanisms in small-cell lung carcinoma].
    Loriot Y; Calderaro J; Soria JC; Deutsch E; Vielh P
    Ann Pathol; 2010 Feb; 30(1):17-24. PubMed ID: 20223350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A human monoclonal antibody targeting the stem cell factor receptor (c-Kit) blocks tumor cell signaling and inhibits tumor growth.
    Lebron MB; Brennan L; Damoci CB; Prewett MC; O'Mahony M; Duignan IJ; Credille KM; DeLigio JT; Starodubtseva M; Amatulli M; Zhang Y; Schwartz KD; Burtrum D; Balderes P; Persaud K; Surguladze D; Loizos N; Paz K; Kotanides H
    Cancer Biol Ther; 2014 Sep; 15(9):1208-18. PubMed ID: 24921944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.